Royal Bank of Canada’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-211,076
Closed -$1.52M 7918
2023
Q1
$1.52M Buy
211,076
+10,309
+5% +$80K ﹤0.01% 3019
2022
Q4
$1.65M Buy
200,767
+163,059
+432% +$1.52M ﹤0.01% 3070
2022
Q3
$398K Sell
37,708
-7,412
-16% -$78.8K ﹤0.01% 4220
2022
Q2
$416K Sell
45,120
-8,815
-16% -$72.1K ﹤0.01% 4242
2022
Q1
$371K Buy
53,935
+20,050
+59% +$129K ﹤0.01% 4523
2021
Q4
$273K Buy
33,885
+23,024
+212% +$153K ﹤0.01% 5036
2021
Q3
$67K Buy
10,861
+4,327
+66% +$16.4K ﹤0.01% 5988
2021
Q2
$20K Buy
6,534
+4,673
+251% +$17.8K ﹤0.01% 6575
2021
Q1
$7K Buy
1,861
+4
+0.2% +$15 ﹤0.01% 6967
2020
Q4
$6K Buy
1,857
+1,798
+3,047% +$4.87K ﹤0.01% 6608
2020
Q3
$0 Sell
59
-3,691
-98% -$10.5K ﹤0.01% 7066
2020
Q2
$39K Hold
3,750
﹤0.01% 5335
2020
Q1
$37K Buy
3,750
+567
+18% +$5.05K ﹤0.01% 5298
2019
Q4
$24K Sell
3,183
-3,099
-49% -$21.2K ﹤0.01% 5788
2019
Q3
$40K Buy
+6,282
New +$44.3K ﹤0.01% 5217

Other funds holding BLU

Royal Bank of Canada's BLU Position: Q2 2023 in Review

Royal Bank of Canada sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 211,076 shares — an estimated $1.52M sold.

Royal Bank of Canada first reported a position in BLU in Q3 2019 and held it in 15 quarters. The position peaked at $1.65M in Q4 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Royal Bank of Canada reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 211,076 BELLUS Health Inc. shares in Q2 2023, an estimated $1.52M.
  • Royal Bank of Canada first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 15 quarters.
  • Royal Bank of Canada's BELLUS Health Inc. position peaked at $1.65M in Q4 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.